|
NFE2L2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.520200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.819340E-03 |
| Normal-vs-Stage2 |
3.817500E-02 |
| Normal-vs-Stage3 |
6.665200E-01 |
| Normal-vs-Stage4 |
4.088200E-01 |
| Stage1-vs-Stage2 |
8.352400E-01 |
| Stage1-vs-Stage3 |
1.112430E-01 |
| Stage1-vs-Stage4 |
6.246400E-01 |
| Stage2-vs-Stage3 |
2.713000E-01 |
| Stage2-vs-Stage4 |
7.238400E-01 |
| Stage3-vs-Stage4 |
6.195000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.243800E-03 |
| Normal-vs-AfricanAmerican |
4.447600E-02 |
| Normal-vs-Asian |
6.422400E-02 |
| Caucasian-vs-AfricanAmerican |
6.725400E-01 |
| Caucasian-vs-Asian |
7.750600E-01 |
| AfricanAmerican-vs-Asian |
6.441000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.031300E-04 |
| Normal-vs-Female |
8.569000E-01 |
| Male-vs-Female |
4.952200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.156300E-02 |
| Normal-vs-Extreme_Weight |
5.583000E-04 |
| Normal-vs-Obese |
1.304640E-01 |
| Normal-vs-Extreme_Obese |
1.176970E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.168400E-01 |
| Normal_Weight-vs-Obese |
7.429600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.213800E-01 |
| Extreme_Weight-vs-Obese |
1.361780E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.903600E-01 |
| Obese-vs-Extreme_Obese |
4.959000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.299000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.815900E-02 |
| Normal-vs-Age(61-80Yrs) |
2.643200E-04 |
| Normal-vs-Age(81-100Yrs) |
2.091800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.612200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.696000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.026600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.629900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.510200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.098600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.700600E-03 |
| Normal-VS-Type2 PRCC |
5.360100E-02 |
| Normal-VS-KIRP CIMP |
9.715400E-01 |
| Normal-VS-Unclassified PRCC |
5.863500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.591000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.950750E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.933200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.995400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.112000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.987600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.05289999999358E-05 |
| Normal-vs-N1 |
5.355400E-01 |
| Normal-vs-N2 |
1.441780E-01 |
| N0-vs-N1 |
3.702200E-03 |
| N0-vs-N2 |
5.700600E-01 |
| N1-vs-N2 |
3.199200E-01 |
|
|
